42/100

Arcellx Inc

ACLXCell Therapy

📋

Analyst Summary

✓ VERIFIED2026-04-11

Arcellx Inc (ACLX) is the lead sponsor of 1 active clinical trials listed on ClinicalTrials.gov^[2], including 1 Phase 1^[1].

ACLX has 1 Form 4 insider filing recorded at the SEC in the past 30 days^[3].

Sources

ClinicalTrials.gov (2026-04-11) ↗
ClinicalTrials.gov (2026-04-11) ↗
SEC EDGAR · 0001786205 (2026-04-11) ↗

🔬

Clinical Trials

NCT06626919Muscular Diseases, Neuromuscular Manifestations, Autoimmune, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Myasthenia Gravis, Muscle Weakness

Source ↗

clinicaltrials_gov · Retrieved 2026-04-11

👤

Insider Activity

1 filing

Source ↗

sec_edgar · Retrieved 2026-04-11

Not financial advice. BiotechSigns profiles are AI-generated from verified public sources (ClinicalTrials.gov, SEC EDGAR) and are for informational purposes only. Always do your own due diligence before making investment decisions.

Score Breakdown

Score Trend

2026-04-132026-06-02

Signal Summary

PDUFA Dates0

Insider Filings1

Clinical Trials1

Sector Peers (Cell Therapy)

ATRAAtara Biotherapeutics

VORVor Biopharma

IOVAIovance Biotherapeutics

FATEFate Therapeutics